[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe eterinary Vaccines Market Report 2016

October 2016 | 127 pages | ID: E08931A0B81EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of eterinary Vaccines

Revenue, means the sales value of eterinary Vaccines

This report studies sales (consumption) of eterinary Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • GE Healthcare
  • Bayer Healthcare
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco Animal Health (Eli Lilly)
  • Heska Corporation
  • Merck Animal Healthcare
  • Merial Inc. (SANOFI)
  • Virbac
  • Zoetis
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of eterinary Vaccines in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Companion Animal Vaccines
  • Livestock Vaccines
  • Poultry Vaccines
  • Porcine Vaccines
  • Equine Vaccines
  • Aquaculture Vaccines
  • Other Animal Vaccines
Split by application, this report focuses on sales, market share and growth rate of eterinary Vaccines in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe eterinary Vaccines Market Report 2016

1 ETERINARY VACCINES OVERVIEW

1.1 Product Overview and Scope of eterinary Vaccines
1.2 Classification of eterinary Vaccines
  1.2.1 Companion Animal Vaccines
  1.2.2 Livestock Vaccines
  1.2.3 Poultry Vaccines
  1.2.4 Porcine Vaccines
  1.2.5 Equine Vaccines
  1.2.6 Aquaculture Vaccines
  1.2.7 Other Animal Vaccines
1.3 Application of eterinary Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 eterinary Vaccines Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of eterinary Vaccines (2011-2021)
  1.5.1 Europe eterinary Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Europe eterinary Vaccines Revenue and Growth Rate (2011-2021)

2 EUROPE ETERINARY VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe eterinary Vaccines Market Competition by Manufacturers
  2.1.1 Europe eterinary Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe eterinary Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe eterinary Vaccines (Volume and Value) by Type
  2.2.1 Europe eterinary Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Europe eterinary Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe eterinary Vaccines (Volume and Value) by Countries
  2.3.1 Europe eterinary Vaccines Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe eterinary Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe eterinary Vaccines (Volume) by Application

3 GERMANY ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany eterinary Vaccines Sales and Value (2011-2016)
  3.1.1 Germany eterinary Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 Germany eterinary Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 Germany eterinary Vaccines Sales Price Trend (2011-2016)
3.2 Germany eterinary Vaccines Sales and Market Share by Manufacturers
3.3 Germany eterinary Vaccines Sales and Market Share by Type
3.4 Germany eterinary Vaccines Sales and Market Share by Application

4 FRANCE ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 France eterinary Vaccines Sales and Value (2011-2016)
  4.1.1 France eterinary Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 France eterinary Vaccines Revenue and Growth Rate (2011-2016)
  4.1.4 France eterinary Vaccines Sales Price Trend (2011-2016)
4.2 France eterinary Vaccines Sales and Market Share by Manufacturers
4.3 France eterinary Vaccines Sales and Market Share by Type
4.4 France eterinary Vaccines Sales and Market Share by Application

5 UK ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 UK eterinary Vaccines Sales and Value (2011-2016)
  5.1.1 UK eterinary Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 UK eterinary Vaccines Revenue and Growth Rate (2011-2016)
  5.1.5 UK eterinary Vaccines Sales Price Trend (2011-2016)
5.2 UK eterinary Vaccines Sales and Market Share by Manufacturers
5.3 UK eterinary Vaccines Sales and Market Share by Type
5.4 UK eterinary Vaccines Sales and Market Share by Application

6 RUSSIA ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia eterinary Vaccines Sales and Value (2011-2016)
  6.1.1 Russia eterinary Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Russia eterinary Vaccines Revenue and Growth Rate (2011-2016)
  6.1.6 Russia eterinary Vaccines Sales Price Trend (2011-2016)
6.2 Russia eterinary Vaccines Sales and Market Share by Manufacturers
6.3 Russia eterinary Vaccines Sales and Market Share by Type
6.4 Russia eterinary Vaccines Sales and Market Share by Application

7 ITALY ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy eterinary Vaccines Sales and Value (2011-2016)
  7.1.1 Italy eterinary Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 Italy eterinary Vaccines Revenue and Growth Rate (2011-2016)
  7.1.7 Italy eterinary Vaccines Sales Price Trend (2011-2016)
7.2 Italy eterinary Vaccines Sales and Market Share by Manufacturers
7.3 Italy eterinary Vaccines Sales and Market Share by Type
7.4 Italy eterinary Vaccines Sales and Market Share by Application

8 SPAIN ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain eterinary Vaccines Sales and Value (2011-2016)
  8.1.1 Spain eterinary Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Spain eterinary Vaccines Revenue and Growth Rate (2011-2016)
  8.1.8 Spain eterinary Vaccines Sales Price Trend (2011-2016)
8.2 Spain eterinary Vaccines Sales and Market Share by Manufacturers
8.3 Spain eterinary Vaccines Sales and Market Share by Type
8.4 Spain eterinary Vaccines Sales and Market Share by Application

9 BENELUX ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux eterinary Vaccines Sales and Value (2011-2016)
  9.1.1 Benelux eterinary Vaccines Sales and Growth Rate (2011-2016)
  9.1.2 Benelux eterinary Vaccines Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux eterinary Vaccines Sales Price Trend (2011-2016)
9.2 Benelux eterinary Vaccines Sales and Market Share by Manufacturers
9.3 Benelux eterinary Vaccines Sales and Market Share by Type
9.4 Benelux eterinary Vaccines Sales and Market Share by Application

10 EUROPE ETERINARY VACCINES MANUFACTURERS ANALYSIS

10.1 GE Healthcare
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 eterinary Vaccines Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Bayer Healthcare
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 eterinary Vaccines Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 eterinary Vaccines Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Ceva Animal Health
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 eterinary Vaccines Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Elanco Animal Health (Eli Lilly)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 eterinary Vaccines Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Heska Corporation
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 eterinary Vaccines Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Merck Animal Healthcare
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 eterinary Vaccines Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Merial Inc. (SANOFI)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 eterinary Vaccines Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Virbac
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 eterinary Vaccines Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Zoetis
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 eterinary Vaccines Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Zoetis eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 ETERINARY VACCINES MANUFACTURING COST ANALYSIS

11.1 eterinary Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of eterinary Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 eterinary Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ETERINARY VACCINES MARKET FORECAST (2016-2021)

14.1 Germany eterinary Vaccines Sales Forecast (2016-2021)
14.2 France eterinary Vaccines Sales Forecast (2016-2021)
14.3 UK eterinary Vaccines Sales Forecast (2016-2021)
14.4 Russia eterinary Vaccines Sales Forecast (2016-2021)
14.5 Italy eterinary Vaccines Sales Forecast (2016-2021)
14.6 Spain eterinary Vaccines Sales Forecast (2016-2021)
14.7 Benelux eterinary Vaccines Sales Forecast (2016-2021)
14.8 Europe eterinary Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe eterinary Vaccines Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of eterinary Vaccines
Table Classification of eterinary Vaccines
Figure Europe Sales Market Share of eterinary Vaccines by Type in 2015
Figure Companion Animal Vaccines Picture
Figure Livestock Vaccines Picture
Figure Poultry Vaccines Picture
Figure Porcine Vaccines Picture
Figure Equine Vaccines Picture
Figure Aquaculture Vaccines Picture
Figure Other Animal Vaccines Picture
Table Application of eterinary Vaccines
Figure Europe Sales Market Share of eterinary Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure France eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure UK eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux eterinary Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe eterinary Vaccines Sales and Growth Rate (2011-2021)
Figure Europe eterinary Vaccines Revenue and Growth Rate (2011-2021)
Table Europe eterinary Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe eterinary Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 eterinary Vaccines Sales Share by Manufacturers
Figure 2016 eterinary Vaccines Sales Share by Manufacturers
Table Europe eterinary Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe eterinary Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe eterinary Vaccines Revenue Share by Manufacturers
Table 2016 Europe eterinary Vaccines Revenue Share by Manufacturers
Table Europe eterinary Vaccines Sales and Market Share by Type (2011-2016)
Table Europe eterinary Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of eterinary Vaccines by Type (2011-2016)
Figure Europe eterinary Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe eterinary Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe eterinary Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of eterinary Vaccines by Type (2011-2016)
Figure Europe eterinary Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe eterinary Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe eterinary Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of eterinary Vaccines by Countries (2011-2016)
Table Europe eterinary Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe eterinary Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of eterinary Vaccines by Countries (2011-2016)
Table Europe eterinary Vaccines Sales and Market Share by Application (2011-2016)
Table Europe eterinary Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of eterinary Vaccines by Application (2011-2016)
Figure Germany eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure Germany eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany eterinary Vaccines Sales Price Trend (2011-2016)
Table Germany eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany eterinary Vaccines Sales by Type (2015 and 2016)
Table Germany eterinary Vaccines Market Share by Type (2015 and 2016)
Table Germany eterinary Vaccines Sales by Application (2015 and 2016)
Table Germany eterinary Vaccines Market Share by Application (2015 and 2016)
Figure France eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure France eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure France eterinary Vaccines Sales Price Trend (2011-2016)
Table France eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table France eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table France eterinary Vaccines Sales by Type (2015 and 2016)
Table France eterinary Vaccines Market Share by Type (2015 and 2016)
Table France eterinary Vaccines Sales by Application (2015 and 2016)
Table France eterinary Vaccines Market Share by Application (2015 and 2016)
Figure UK eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure UK eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure UK eterinary Vaccines Sales Price Trend (2011-2016)
Table UK eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table UK eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK eterinary Vaccines Sales by Type (2015 and 2016)
Table UK eterinary Vaccines Market Share by Type (2015 and 2016)
Table UK eterinary Vaccines Sales by Application (2015 and 2016)
Table UK eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Russia eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure Russia eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia eterinary Vaccines Sales Price Trend (2011-2016)
Table Russia eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia eterinary Vaccines Sales by Type (2015 and 2016)
Table Russia eterinary Vaccines Market Share by Type (2015 and 2016)
Table Russia eterinary Vaccines Sales by Application (2015 and 2016)
Table Russia eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Italy eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure Italy eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy eterinary Vaccines Sales Price Trend (2011-2016)
Table Italy eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy eterinary Vaccines Sales by Type (2015 and 2016)
Table Italy eterinary Vaccines Market Share by Type (2015 and 2016)
Table Italy eterinary Vaccines Sales by Application (2015 and 2016)
Table Italy eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Spain eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure Spain eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain eterinary Vaccines Sales Price Trend (2011-2016)
Table Spain eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain eterinary Vaccines Sales by Type (2015 and 2016)
Table Spain eterinary Vaccines Market Share by Type (2015 and 2016)
Table Spain eterinary Vaccines Sales by Application (2015 and 2016)
Table Spain eterinary Vaccines Market Share by Application (2015 and 2016)
Figure Benelux eterinary Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux eterinary Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux eterinary Vaccines Sales Price Trend (2011-2016)
Table Benelux eterinary Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux eterinary Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux eterinary Vaccines Sales by Type (2015 and 2016)
Table Benelux eterinary Vaccines Market Share by Type (2015 and 2016)
Table Benelux eterinary Vaccines Sales by Application (2015 and 2016)
Table Benelux eterinary Vaccines Market Share by Application (2015 and 2016)
Table eterinary Vaccines Basic Information List
Table GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare eterinary Vaccines Sales Market Share (2011-2016)
Table Bayer Healthcare Basic Information List
Table Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare eterinary Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim eterinary Vaccines Sales Market Share (2011-2016)
Table Ceva Animal Health Basic Information List
Table Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Animal Health eterinary Vaccines Sales Market Share (2011-2016)
Table Elanco Animal Health (Eli Lilly) Basic Information List
Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales Market Share (2011-2016)
Table Heska Corporation Basic Information List
Table Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation eterinary Vaccines Sales Market Share (2011-2016)
Table Merck Animal Healthcare Basic Information List
Table Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Healthcare eterinary Vaccines Sales Market Share (2011-2016)
Table Merial Inc. (SANOFI) Basic Information List
Table Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Inc. (SANOFI) eterinary Vaccines Sales Market Share (2011-2016)
Table Virbac Basic Information List
Table Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac eterinary Vaccines Sales Market Share (2011-2016)
Table Zoetis Basic Information List
Table Zoetis eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis eterinary Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of eterinary Vaccines
Figure Manufacturing Process Analysis of eterinary Vaccines
Figure eterinary Vaccines Industrial Chain Analysis
Table Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015
Table Major Buyers of eterinary Vaccines
Table Distributors/Traders List
Figure Germany eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe eterinary Vaccines Sales Forecast by Type (2016-2021)
Table Europe eterinary Vaccines Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories